secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001104659-22-116545
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals reports Q3 2022 results; financial details not provided in filing excerpt
--------------------------------------------------------------------------------

- Company reported financial and operating results for Q3 2022 ended September 30, 2022.
- Exhibit 99.1 contains conference call transcript but no specific financial figures in provided excerpt.
- Investors should refer to full press release for revenue, EPS, and segment details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000110465922116545/0001104659-22-116545-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000110465922116545/tm2230118d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-116545

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer